US 9035041
Process for triphosphate oligonucleotide synthesis
granted A61PA61P25/00A61P31/04
Quick answer
US patent 9035041 (Process for triphosphate oligonucleotide synthesis) held by Alnylam Pharmaceuticals, Inc. expires Mon May 14 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Alnylam Pharmaceuticals, Inc.
- Grant date
- Tue May 19 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 14 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 21
- CPC classes
- A61P, A61P25/00, A61P31/04, A61P31/12, A61P31/18